Global Bone Marrow Transplantation Analysis and Market Growth, Trend, Research, Study and Forecast 2014

MarketResearchReports.Biz announces addition of new report “Bone Marrow Transplantation - Pipeline Review, H1 2014” to its database. Visit: http://www.marketresearchreports.biz/analysis/187343.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketResearchReports.biz

MarketResearchReports.biz

Albany, NY (PRWEB) February 18, 2014

Global Markets Directs, 'Bone Marrow Transplantation Pipeline Review, H1 2014', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bone Marrow Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Marrow Transplantation. Bone Marrow Transplantation Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

Browse Complete report with TOC : http://www.marketresearchreports.biz/analysis-details/bone-marrow-transplantation-pipeline-review-h1-2014.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  •     A snapshot of the global therapeutic scenario for Bone Marrow Transplantation.
  •     A review of the Bone Marrow Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  •     Coverage of products based on various stages of development ranging from discovery till registration stages.
  •     A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  •     Coverage of the Bone Marrow Transplantation pipeline on the basis of route of administration and molecule type.
  •     Key discontinued pipeline projects.
  •     Latest news and deals relating to the products.

To Download Sample Report Visit : http://www.marketresearchreports.biz/sample/sample/187343.

Reasons to buy

  •     Identify and understand important and diverse types of therapeutics under development for Bone Marrow Transplantation.
  •     Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  •     Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  •     Devise corrective measures for pipeline projects by understanding Bone Marrow Transplantation pipeline depth and focus of Indication therapeutics.
  •     Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  •     Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

To buy this Report : http://www.marketresearchreports.biz/analysis/187343.

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Bone Marrow Transplantation Overview

Therapeutics Development

Pipeline Products for Bone Marrow Transplantation - Overview

Pipeline Products for Bone Marrow Transplantation - Comparative Analysis

Bone Marrow Transplantation - Therapeutics under Development by Companies

Bone Marrow Transplantation - Therapeutics under Investigation by Universities/Institutes

Bone Marrow Transplantation - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Bone Marrow Transplantation - Products under Development by Companies

Bone Marrow Transplantation - Products under Investigation by Universities/Institutes

Bone Marrow Transplantation - Companies Involved in Therapeutics Development

Mesoblast Limited

Cleveland BioLabs, Inc

Pluristem Therapeutics Inc.

Spectrum Pharmaceuticals, Inc

TikoMed AB

Bone Marrow Transplantation - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Assessment by Therapeutic Class

Drug Profiles

Allogeneic MPC For Bone Marrow Transplantation - Drug Profile

Product Description

Mechanism of Action

R&D Progress

melphalan - Drug Profile

Product Description

Mechanism of Action

R&D Progress

TM-400 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

PLX-BMP - Drug Profile

Product Description

Mechanism of Action

R&D Progress

CBLB-612 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

CBLB-612 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Perforin Inhibitor - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Bone Marrow Transplantation - Recent Pipeline Updates

Bone Marrow Transplantation - Dormant Projects

Bone Marrow Transplantation - Discontinued Products

Bone Marrow Transplantation - Product Development Milestones

Featured News & Press Releases

Nov 13, 2013: Improved Survival In Children With Life Threatening Graft Versus Host Disease Reported After Treatment With Mesoblast\'s Cell Therapy

Nov 04, 2013: Enlivex Therapeutics Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients

Oct 29, 2013: Pharmalink Receives US Orphan Drug Designation for Busulipo, its Novel Oncology Product for Bone Marrow Transplantation

Sep 03, 2013: BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells

May 07, 2013: Pluristem Develops PLX-RAD Cells For Use In Hematology

Dec 05, 2012: URMC Researchers Test New Approach To Accelerate Blood Stem Cells

Nov 06, 2012: Cleveland BioLabs Announces Publication Of Studies On Effect Of Entolimod On Graft-versus-tumor Activity In Models Of Allogeneic Bone Marrow Transplantation

Oct 24, 2012: Enlivex Therapeutics Completes Clinical Trial For Treatment Of Bone Marrow Transplant Recipients, Reports Positive Results

Sep 05, 2012: Pluristem Therapeutics Announces Successfully Treatment Of Third Critically Ill Patient With PLX Cells Under Compassionate Use

Aug 06, 2012: Pluristem\'s PLX Cells Save Life Of Cancer Patient Suffering From Bone Marrow Failure

Contact US:

Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales(at)marketresearchreports(dot)biz
Blog: http://mresearchreports.blogspot.com